Weather , , 0°C

Candidemia Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

 Breaking News
  • No posts were found

Candidemia Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

June 02
21:26 2021
Candidemia Market Analysis, Market Size, Epidemiology, Leading Companies And Competitive Analysis By DelveInsight

DelveInsight Business Research LLP
DelveInsight’s “Candidemia–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Candidemia-Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’s “Candidemia–Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Candidemia, historical and forecasted epidemiology as well as the Candidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

 

  1. Age is an important factor in the progression of the disease. In 2017, there were 9,462 cases in the age group of 65 years and above, which was the highest in any age group in the US. This was followed by 7,707 cases in the age group of 45–64 years. These numbers will increase to 10,465 and 8,523 cases in the age group of 65 and above and 45–64 years, respectively, in the US, by 2030.

  2. Among the European countries, Spain had the highest population of candidemia with 6,110 cases, followed by Germany,which had  3,482 cases in 2017In 2017, incident cases of candidemia in the US varied according to gender; 10,237 females and  12,563 males. These cases are expected to increase by 2030.

  3. Among the EU5 countries, the UK had the lowest incident population with 2,332 cases in 2017.

  4. The incident population of candidemia in Japan was 916 cases in 2017.

Key benefits of the report:

1.The Candidemia market report covers a descriptive overview and comprehensive insight of the Candidemia epidemiology and Candidemia market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.The Candidemia market report provides insights into the current and emerging therapies.

3.Candidemia market report provides a global historical and forecasted market covering drug outreach in 7MM.

4.The Candidemia market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Candidemia market.

Request for sample pages: https://www.delveinsight.com/sample-request/candidemia-market

Candidemia: Overview

Candidemia is the most common fungal bloodstream infection and possibly the fourth most common all-type bloodstream infection seen in the intensive care unit setting. The incidence of Candida bloodstream infection is bimodal, with the elderly and very young having the highest risk of any population suffering from this disease.

The key players involved in the Candidemia market:

 

  1. Amplyx Pharmaceuticals

  2. Cidara Therapeutics

  3. Scynexis

The launch of the emerging therapies is expected to significantly impact the  Candidemia treatment scenario in the upcoming years:-

Drug covered

  1. APX001

  2. CD101

  3. SCY-078

Request a free sample report @https://www.delveinsight.com/sample-request/candidemia-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Candidemia Patient Share (%) Overview at a Glance

5. Candidemia Market Overview at a Glance

6. Candidemia Disease Background and Overview

7. Candidemia Epidemiology and Patient Population

8. Country-Specific Patient Population of Candidemia 

9. Candidemia Current Treatment and Medical Practices

10. Unmet Needs

11. Candidemia Emerging Therapies

12. Candidemia Market Outlook

13. Country-Wise Candidemia Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Candidemia Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Candidemia-Pipeline Insights, 2021

“Candidemia-Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Candidemia market. A detailed picture of the Candidemia pipeline landscape is provided, which includes the disease overview and Candidemia treatment guidelines.

Candidemia-Epidemiology Forecast to 2030

DelveInsight’s ‘Candidemia-Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Candidemia {;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/

Related Articles

Calendar

December 2021
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Categories